US company Ocugen announced Friday that it had asked authorities for emergency use authorization for Covid-19 vaccine Covaxin, which was developed in India, for ages 2 to 18.
from NDTV News - India-news https://ift.tt/3bIUCMT
via IFTTT
Friday, November 5, 2021
Home »
IFTTT
,
NDTV News - India-news
» Bharat Biotech's Covaxin Approval Requested In US For Children Below 18
0 comments:
Post a Comment